Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]

Por Zhaolai Qi, Ting Zhang, Lei Song, Hongyong Fu, Haifeng Luo, Jie Wu, Shuyun Zhao, Tianhua Zhang, Lianying Guo, Lingling Jin, He Zhang, Gena Huang, Tonghui Ma, Yingjie Wu, Lin Huang
Publicado em 2020-10-01